Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.docVIP

下载本文档

6
0
约3.21万字
约 7页
2017-05-15 发布于上海
举报

Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.doc

Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis

Stavropoulos-Kalinoglouetal.ArthritisResearchTherapy2012,14:R160 /content/14/4/R160 RESEARCH ARTICLE OpenAccess Anti-tumournecrosisfactoralphatherapy improvesinsulinsensitivityinnormal-weightbut notinobesepatientswithrheumatoidarthritis AntoniosStavropoulos-Kalinoglou1,2,3*,GiorgosSMetsios3,4,VasileiosFPanoulas3,PeterNightingale5, YiannisKoutedakis1,2 andGeorgeDKitas3,6 Abstract Introduction:Insulinresistance(IR),ariskfactorforthedevelopmentofcardiovasculardisease,iscommonamong patientswithrheumatoidarthritis(RA).Inflammation,andespeciallytumournecrosisfactoralpha(TNFa),hasbeen associatedwi

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.docVIP